Skip to main content

Table 3 Treatment recommendations of the panel and follow-up of patients

From: Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy

 

No. of patients (n = 45)

No. of patients following treatment recommendation (n = 38)

No. of patients with follow-up available (n = 22)

Confirmed SRT of the prostate bed

26/45

19/26

13/19

Treatment changed

19/45

19/19

9/19

 Dose escalation RT

6

6

6

  • To mLoc rec

• 5

• 5

• 2

  • Brachytherapy of mLoc rec

• 1

• 1

• –

 SRT extended to LN, including boost

8

8b

5

 SRT extended to rectal wall

1

1c

–

 SRT to LN and single bone metastasis

1

1

–

 Multimodal concepta

1

1

1

 ADT

2

2

1d

  1. mLoc rec morphological local recurrence, LN lymph nodes
  2. aSurgery of rectal soft tissue metastasis, SRT of prostate bed, and RT to rectal wall metastasis (due to R2 resection of metastasis)
  3. bTherapy was canceled in two patients due to rising PSA levels during RT
  4. cTherapy was canceled due to rising PSA levels
  5. dNot included in follow-up calculations